For example, GLP-2r agonists have been used in the treatment of inflammatory bowel diseases (such as Crohn’s disease and ulcerative colitis) (25) because they can promote intestinal mucosal repair and regeneration, improving patients’ symptoms and quality of life. Here, GLP2R is linked to inflammatory bowel disease.